Lifechart, a burgeoning name in the gut wellness sector, has successfully raised $500,000 in a recent seed funding round. This financial boost is set to propel the brand’s mission to address gut health issues in India, leveraging advanced technology and expert insights. With a focus on tier 1 cities, Lifechart aims to make significant strides in the wellness market.
Funding Breakdown: Who’s Investing?
The latest funding round saw significant contributions from various investors. Prajay Advisors LLP led the charge with a generous $250,000 investment. The remaining funds were sourced from Agility Ventures, Expert Dojo, and a collective of angel investors, including notable names like Ahana Gautam, Nitish Mittersain, Sarath Sura, and Marwari Angels.
- Key Investors:
- Prajay Advisors LLP: $250,000
- Agility Ventures: Amount undisclosed
- Expert Dojo: Amount undisclosed
- Angel Investors: Various contributions
This funding follows a previous pre-seed round in 2022, where Lifechart secured $200,000 from Expert Dojo and Nazara Technologies’ Nitish Mittersain. The momentum from these investments highlights growing confidence in Lifechart’s vision and potential.
Aiming for Innovation in Gut Health
Lifechart’s co-founders, Mukul Shah and Mansi Sharma, are on a mission to tackle the rising gut health concerns in India. Their approach combines AI-driven predictive technology with products developed by qualified BAMS and BHMS doctors. This unique blend of expertise and innovation positions Lifechart to offer tailored solutions for a variety of gut-related issues.
The brand plans to roll out a range of plant-based, microbiome-focused products. These offerings will include comprehensive wellness kits designed to address common gut problems such as:
- Constipation
- Fatty liver
- Piles
- Gas
- Acidity
By focusing on these prevalent issues, Lifechart aims to provide effective solutions that resonate with consumers seeking better gut health.
Market Potential: A Growing Opportunity
The global gut health market is projected to reach a staggering $18 billion by 2025-26, presenting a lucrative opportunity for Lifechart. With their innovative approach and commitment to quality, the brand is well-positioned to capture a significant share of this expanding market.
Lifechart’s predictive AI model is designed to customize services based on demographic and regional health patterns. This strategy has already made a positive impact on over 250,000 customers, primarily in tier II, III, and IV cities. By understanding the unique health needs of these populations, Lifechart is set to make a meaningful difference in the wellness landscape.
Comments